使TNBC,

Inho Park1,2, Su-Jin Shin1, Heounjeong Go3

  • 1Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

PubMed
概括

具有高CD8+和CD20+免疫细胞的三阴性乳腺癌 (TNBC) 患者对新辅助化疗 (NAC) 的反应更好. B细胞和T细胞的相互作用是预测TNBC中NAC反应的关键.